# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-18-225295
Filing Date
2018-07-25
Accepted
2018-07-25 08:30:38
Documents
22
Period of Report
2018-07-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d549570d8k.htm | 8-K | 16784
2 | EX-99.1 | d549570dex991.htm | EX-99.1 | 22812
3 | EX-99.2 | d549570dex992.htm | EX-99.2 | 21072
4 | GRAPHIC | g549570ex99_2s10g1.jpg | GRAPHIC | 391697
5 | GRAPHIC | g549570ex99_2s11g1.jpg | GRAPHIC | 367367
6 | GRAPHIC | g549570ex99_2s12g1.jpg | GRAPHIC | 250936
7 | GRAPHIC | g549570ex99_2s13g1.jpg | GRAPHIC | 341448
8 | GRAPHIC | g549570ex99_2s14g1.jpg | GRAPHIC | 76577
9 | GRAPHIC | g549570ex99_2s15g1.jpg | GRAPHIC | 327796
10 | GRAPHIC | g549570ex99_2s16g1.jpg | GRAPHIC | 238642
11 | GRAPHIC | g549570ex99_2s17g1.jpg | GRAPHIC | 299895
12 | GRAPHIC | g549570ex99_2s18g1.jpg | GRAPHIC | 183573
13 | GRAPHIC | g549570ex99_2s19g1.jpg | GRAPHIC | 542323
14 | GRAPHIC | g549570ex99_2s1g1.jpg | GRAPHIC | 547022
15 | GRAPHIC | g549570ex99_2s2g1.jpg | GRAPHIC | 602983
16 | GRAPHIC | g549570ex99_2s3g1.jpg | GRAPHIC | 234625
17 | GRAPHIC | g549570ex99_2s4g1.jpg | GRAPHIC | 206206
18 | GRAPHIC | g549570ex99_2s5g1.jpg | GRAPHIC | 346340
19 | GRAPHIC | g549570ex99_2s6g1.jpg | GRAPHIC | 279720
20 | GRAPHIC | g549570ex99_2s7g1.jpg | GRAPHIC | 418189
21 | GRAPHIC | g549570ex99_2s8g1.jpg | GRAPHIC | 283957
22 | GRAPHIC | g549570ex99_2s9g1.jpg | GRAPHIC | 305145
| Complete submission text file | 0001193125-18-225295.txt |  | 8664158

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 18967742
SIC: 2834 Pharmaceutical Preparations